Literature DB >> 4010475

Interaction of choline and scopolamine in human memory.

R C Mohs, K L Davis.   

Abstract

In a previous study (1), 8 gm. of oral choline given in a single dose were found to partially reverse the amnestic and subjective effects of 0.43 mg of scopolamine. The present study determined whether similar effects could be produced by 14 gm of choline given in 4 divided doses over 24 hrs and whether choline's effects in either study were related to plasma choline concentration. Ten normal subjects were given memory tests on three separate days, once after receiving 14 gm choline and 0.35 mg scopolamine (Ch-Sc), once following placebo and scopolamine (Pl-Sc), and once following placebo and placebo (Pl-Pl). Scopolamine markedly impaired memory performance but there was no difference between the Ch-Sc and Pl-Sc conditions. Plasma choline levels were significantly elevated in the Ch-Sc condition of both the single dose and divided dose studies. There was no difference in levels between studies nor were differences in memory performance correlated with elevations in plasma choline. These results indicate that any enhancement of cholinergic activity due to increased dietary choline is transient and of small magnitude.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4010475     DOI: 10.1016/0024-3205(85)90423-0

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Reversal of scopolamine-induced amnesia of passive avoidance by pre- and post-training naloxone.

Authors:  D K Rush
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  The effects of scopolamine on working memory in healthy young volunteers.

Authors:  J M Rusted; D M Warburton
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Dissociative effects of scopolamine on working memory in healthy young volunteers.

Authors:  J M Rusted
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Pharmacological models in Alzheimer's disease research.

Authors:  C Gilles; S Ertlé
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

5.  Human models as tools in the development of psychotropic drugs.

Authors:  Christian Gilles; Thérèse Schunck; Gilles Erb; Izzie Jacques Namer; Yann Hodé; Jean-François Nedelec; Peter Boeijinga; Remy Luthringer; Jean-Paul Mâcher
Journal:  Dialogues Clin Neurosci       Date:  2002-12       Impact factor: 5.986

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.